Is Travoprost Ophthalmic Solution in shortage?
Travoprost Ophthalmic Solution is listed by FDA as being discontinued by at least one maker (updated Jul 7, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Travoprost, Ophthalmic Solution, 0.004%, 2.5 mL (NDC 0378-9651-32)
Discontinuation of the manufacture of the drug
Maker contact: 877-446-3679
- Travoprost, Ophthalmic Solution, 0.004%, 5 mL (NDC 0378-9651-50)
Discontinuation of the manufacture of the drug
Maker contact: 877-446-3679
FDA recalls of Travoprost
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Travoprost Ophthalmic Solution:
- Golden State Medical Supply Inc. recalls Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc.,
- Mylan Pharmaceuticals Inc recalls Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc.,
- Cardinal Health Inc. recalls TRAVOPROST OPHTHALMIC SOLUTION, USP 0.004% 2.5ML ; NDC/UPC 60505-0593-4; RX; DROPS
Travoprost Ophthalmic Solution shortage questions
Is Travoprost Ophthalmic Solution in shortage?
Travoprost Ophthalmic Solution is listed by FDA as being discontinued by at least one maker (updated Jul 7, 2026).
What should I do if I can’t get Travoprost Ophthalmic Solution?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.